[Effect of hypertonic saline on lipid peroxidation in pregnant rat]. 1991

F Yamasaki
Department of Obstetrics and Gynecology, Okayama University School of Medicine.

The extent of lipid peroxidation and antioxidation during pregnancy was studied in mothers and fetuses by treating pregnant spontaneous hypertensive rats (SHR) with 1.0%, 1.5% and 2.0% salt water and tap water (control). The treatment with 1% salt water was uneventful, and 2% salt water caused a marked increased in water consumption and occasional deaths in mothers. Study results for the 1.5% salt water (experimental) and control groups, unless otherwise specified were therefore compared at the end of the gestational period. 1) Systolic blood pressure was 170 mmHg before pregnancy in the control. The parameter dropped from day 17 of gestation down to 140 mmHg on day 20. In contrast, the parameter remained essentially constant throughout the gestational period in the experimental group. 2) The mothers in the experimental group had much higher triglyceride levels than the control. 3) Maternal serum and liver tissue concentrations of lipoperoxides were high in the experimental group. 4) Maternal liver tissue levels of antioxidant substances changed considerably during pregnancy; superoxide dismutase (SOD) activity and vitamin E were increased, but catalase activity was decreased. Glutathione peroxidase activity remained almost constant. There were no appreciable changes in lung tissue levels of antioxidant substances. 5) Placental tissues in the experimental group contained lipoperoxides and antioxidant substances in similar amounts to those in the control. 6) Fetal serum concentrations of lipoperoxides were much lower than the maternal levels in both experimental and control groups. In conclusion, placental tissues were believed to have a protective mechanism which prevents placental transfer of lipoperoxides from maternal to fetal blood.

UI MeSH Term Description Entries
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal

Related Publications

F Yamasaki
May 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation,
F Yamasaki
April 1985, British journal of experimental pathology,
F Yamasaki
February 1990, The Journal of toxicological sciences,
F Yamasaki
January 1980, Voprosy meditsinskoi khimii,
F Yamasaki
April 1994, Archives of pharmacal research,
F Yamasaki
January 1989, Chemico-biological interactions,
F Yamasaki
November 1985, Biochemical pharmacology,
Copied contents to your clipboard!